drugset / Trial / NCT01527370
Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)
NaSingle-groupOpen-labelPrevention
Summary
This study will determine if ZOSTAVAX™ is safe, tolerable, and immunogenic in healthy adults in India.
Timeline
- Start
- 2012-10-31
- Primary completion
- 2013-04-09
- Completion
- 2013-04-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varivax | Vaccine | 0.65 ml | Subcutaneous |